Pharmaceutical Technology on MSN2 天
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK
Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
GSK resolves patent lawsuit against Pfizer over RSV vaccines
By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
GSK 举报引发联邦调查，特朗普政府重审旧案
导语： 2025 年 3 月，英国制药巨头葛兰素史克（GSK）向纽约联邦检察官提交内部举报，指控辉瑞（Pfizer）在 2020 年美国总统大选期间刻意推迟公布新冠疫苗 Comirnaty ...
Fierce Pharma7 天
GSK tip claiming Pfizer delayed COVID vaccine results during 2020 election prompts US probe ...
Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...
GSK高级副总裁履新赛诺菲全球研发负责人
4月1日， 据外媒Fierce Biotech报道， 赛诺菲宣布Christopher Corsico 医学博士已离开GSK，成为Sanofi的全球开发主管 ， 向 Sanofi 的研发执行副总裁 Houman Ashrafian ...
European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 ...
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here’s What We Know.
Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
Feds probe disputed tip Pfizer held Covid vaccine results until after 2020 vote: WSJ
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
葛兰素史克举报辉瑞曾推迟发布新冠疫苗消息，美国检方介入调查
据知情人士透露，在去年11月唐纳德·特朗普 (Donald Trump)赢得总统大选后不久，英国制药商 葛兰素史克 (GSK)就向曼哈顿的联邦检察官提出了一项不同寻常的指控。 曾经在葛兰素史克的竞争对手 辉瑞公司 ...
Yahoo Finance2 天
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK
The approval represents another step forward for Pfizer in the RSV vaccine market, where it competes with GSK’s Arexvy. While GSK has secured approval for older adults, it has not yet gained ...